Cubicin Cubist Pharmaceuticals - Treatment for Skin Infections
Cubicin is the first approved product in a new class of antibiotics called cyclic lipopeptide antibacterial agents. Cubicin is indicated for the treatment of complicated skin and skin structure (cSSS) infections caused by Gram-positive bacteria.Posted: September 2003
Related articles
- Cubist Pharmaceuticals Receives FDA Approval for 2-Minute IV Injection of Cubicin - December 2, 2010
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
